Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Treasury Shares (2020 - 2025)

Celularity has reported Treasury Shares over the past 1 years, most recently at $256000.0 for Q4 2020.

  • Quarterly results put Treasury Shares at $256000.0 for Q4 2020, changed N/A from a year ago — trailing twelve months through Dec 2020 was $256000.0 (changed N/A YoY), and the annual figure for FY2020 was $256000.0, changed.
  • Treasury Shares for Q4 2020 was $256000.0 at Celularity.
  • Over the last five years, Treasury Shares for CELU hit a ceiling of $8.8 million in Q3 2023 and a floor of $227013.0 in Q4 2022.
  • Median Treasury Shares over the past 5 years was $570181.0 (2025), compared with a mean of $1.9 million.
  • Biggest five-year swings in Treasury Shares: skyrocketed 1023.42% in 2023 and later plummeted 96.28% in 2024.
  • Celularity's Treasury Shares stood at $474700.0 in 2021, then plummeted by 52.18% to $227013.0 in 2022, then soared by 262.68% to $823332.0 in 2023, then decreased by 19.91% to $659439.0 in 2024, then decreased by 25.97% to $488161.0 in 2025.
  • The last three reported values for Treasury Shares were $488161.0 (Q3 2025), $558530.0 (Q2 2025), and $581832.0 (Q1 2025) per Business Quant data.